Slate Run Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SLATE RUN PHARMA, and what generic and branded alternatives to SLATE RUN PHARMA drugs are available?
SLATE RUN PHARMA has twenty-four approved drugs.
Drugs and US Patents for Slate Run Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Slate Run Pharma | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 209864-002 | Jan 25, 2019 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Slate Run Pharma | SODIUM NITROPRUSSIDE | sodium nitroprusside | SOLUTION;INTRAVENOUS | 215846-003 | Aug 26, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Slate Run Pharma | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 212091-005 | Dec 28, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Slate Run Pharma | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 215821-001 | Nov 18, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Slate Run Pharma | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 212091-002 | Dec 28, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.